TherapeuticsMD Inc (NASDAQ:TXMD) has a beta value of 1.12 and has seen 7.47 million shares traded in the last trading session. The company, currently valued at $15.87M, closed the last trade at $1.47 per share which meant it lost -$0.1 on the day or -6.37% during that session. The TXMD stock price is -87.07% off its 52-week high price of $2.75 and 52.38% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.57 million shares traded. The 3-month trading volume is 146.16K shares.
The consensus among analysts is that TherapeuticsMD Inc (TXMD) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
TherapeuticsMD Inc (NASDAQ:TXMD) trade information
Sporting -6.37% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TXMD stock price touched $1.47 or saw a rise of 39.75%. Year-to-date, TherapeuticsMD Inc shares have moved 70.93%, while the 5-day performance has seen it change 34.86%. Over the past 30 days, the shares of TherapeuticsMD Inc (NASDAQ:TXMD) have changed 9.26%. Short interest in the company has seen 21273.0 shares shorted with days to cover at 0.99.
TherapeuticsMD Inc (TXMD) estimates and forecasts
The company’s shares have lost -2.65% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 49.33% over the past 5 years.
TXMD Dividends
TherapeuticsMD Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
TherapeuticsMD Inc (NASDAQ:TXMD)’s Major holders
Insiders own 1.71% of the company shares, while shares held by institutions stand at 44.53% with a share float percentage of 45.30%. Investors are also buoyed by the number of investors in a company, with TherapeuticsMD Inc having a total of 44.0 institutions that hold shares in the company. The top two institutional holders are RUBRIC CAPITAL MANAGEMENT LP with over 1.19 million shares worth more than $1.92 million. As of 2024-06-30, RUBRIC CAPITAL MANAGEMENT LP held 10.3381% of shares outstanding.
The other major institutional holder is CLEARLINE CAPITAL LP, with the holding of over 0.64 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.02 million and represent 5.5205% of shares outstanding.
